Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

October 22, 2025

Reimbursement Issues Seem to Be Holding Renal Denervation Back

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

December 19, 2024

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

March 29, 2024

The Promise of AI for Improving Health Equity in Heart Failure

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

April 04, 2023

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

October 08, 2021

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

September 28, 2021

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

November 02, 2020

An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19

News Features

An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19

April 14, 2020

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

News Features

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

January 02, 2020

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

Anticoagulation On Demand? The Pill-in-the-Pocket Approach to A-fib Treatment

News Features

Anticoagulation On Demand? The Pill-in-the-Pocket Approach to A-fib Treatment

June 25, 2019

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

January 01, 2019

Calling It Quits: Cath Lab Pioneers Grapple With When to Go and What Comes Next

News Features

Calling It Quits: Cath Lab Pioneers Grapple With When to Go and What Comes Next

February 28, 2018

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

February 26, 2018

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

News Features

Valve, Heal Thyself: Pioneers Seek Tissue-Engineered Fix for Faulty, Failing Cardiac Parts

June 14, 2017

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.